Prof. Dr. Yvonne-Beatrice Böhler

• Consensus on Evidence Gaps and Unmet Needs in Childhood Myopia: Findings from a European Delphi Study with Eye Care Professionals and Payers
• HPR106 Gender-specific Drug Prices in Germany
• HTA161 German Early Benefit Assessments and the Impact of Medical Societies
• HTA33 Analysis of the Implementation of Additive PICOs in a European Joint Health Technology Assessment – Implications of EU-HTA for Pharma
• HTA157 Evidence Transfer in Europea) Drug Approval and (German) Early Benefit Assessments: An Empirical Analysis
• HTA 23 Application-Related Data Collection During Early Benefit Assessments in Germany: An Analysis of Current Procedures
• HTA238 Oncological Combination Therapies in the Context of the Early Benefit Assessment According to AMNOG
• MT45 Digital Health Applications in the General Practitioner Context of Care
• PCN15 DATA Transparency in Oncology — a Quantitative Analysis of Outcome Results in Amnog Documents and Clinicaltrials.Gov
• PMU39 Determinants of Willingness to Copay for Pharmaceuticals in Germany
• PNS175 Presentation of Drug DATA — a Significant Influence on the Assessment of Drugs?
• Die erste von der FDA zugelassene electronic pill
• Game Theory in the Healthcare Literature
• Hochschuldidaktik, Hochschullehre und Hochschullernen - wissenschaftliche Perspektiven auf ihren Stellenwert in der Hochschulentwicklung
• Pharmaceutical Prices: The Impact of the Launch Strategy
• Pharmaceutical Pricing: Launch Strategy Rules?
• Die Aussagekraft der Nachweise im Rahmen der frühen Nutzenbewertung nach AMNOG
• Frühe Nutzenbewertung nach AMNOG
• GKV-VSG in der deutschen Medizinprodukte-Industrie
• Indirect Comparisons presented in German Benefit Assessments
• Open To The Public?
• Time Restricted Decisions in German Benefit Assessments
• An Exploratory Clinicaltrials.gov Review for Patient Reported Outcomes in Cancer Pain
• Assumptions of Mixed Treatment Comparisons in Health Technology Assessments
• How can Payer Requirements be Satisfied when Treatment Switching Occurs?
• Pharmevolution – Wie forscht die pharmazeutische Industrie?
• Epidemiological Data Presented in German Benefit Assessments
• Problemfelder im System - AMNOG
• The German DIMDI Registry

• Hochschuldidaktik erforscht wissenschaftliche Perspektiven auf Lehren und Lernen

Publikationsliste
Publikationsliste (CSV)
Publikationsliste (PDF) im "American Psychological Association 6th edition (DOI)"-Zitierstil
Publikationsliste (PDF) im "Anglia Ruskin University - Harvard"-Zitierstil
Publikationsliste (PDF) im "Gesellschaft für Bildung und Forschung in Europa - Harvard"-Zitierstil

Download
 RDF/XML-Format
 JSON-LD-Format
 Turtle-Format
 N3-Format